cyclopentane has been researched along with Urinary Bladder Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, L; Huang, T; Jiang, G; Tao, D; Wang, L; Wang, M; Wang, Y; Xiang, W; Xiao, X; Zeng, F | 1 |
| Chang, HC; Chiang, CK; Chou, CT; Ho, IL; Hsieh, JT; Hsu, CH; Huang, KH; Kuo, KL; Lin, WC; Liu, SH; Pu, YS; Shi, CS; Tsai, YC; Wu, JT | 1 |
| Jiang, GS; Lv, L; Wang, L; Xiao, XY; Zeng, FQ | 1 |
3 other study(ies) available for cyclopentane and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101.
Topics: Acetates; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cyclopentanes; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; MicroRNAs; Middle Aged; Neoplasm Proteins; Oxylipins; Polycomb Repressive Complex 2; Random Allocation; RNA, Neoplasm; Tumor Cells, Cultured; Urinary Bladder; Urinary Bladder Neoplasms; Xanthones; Xenograft Model Antitumor Assays | 2014 |
MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Carcinoma, Transitional Cell; Caspase 3; Caspase 7; Cell Line, Tumor; Cisplatin; Cyclopentanes; Drug Combinations; Drug Synergism; Gene Expression Regulation, Neoplastic; Histones; Humans; MAP Kinase Kinase 4; Mice; Mice, Nude; NEDD8 Protein; Neoplasm Grading; Poly(ADP-ribose) Polymerases; Pyrimidines; Signal Transduction; Ubiquitins; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Predominant enhancement of apoptosis induced by methyl jasmonate in bladder cancer cells: therapeutic effect of the Antp-conjugated Smac peptide.
Topics: Acetates; Antennapedia Homeodomain Protein; Antineoplastic Agents; Apoptosis; Bisbenzimidazole; Caspase 3; Caspase 9; Cell Survival; Cyclopentanes; Drosophila Proteins; Drug Evaluation, Preclinical; Drug Synergism; Fluorescent Dyes; HEK293 Cells; Humans; Inhibitor of Apoptosis Proteins; Molecular Targeted Therapy; Oligopeptides; Oxylipins; Survivin; Tumor Cells, Cultured; Urinary Bladder Neoplasms; X-Linked Inhibitor of Apoptosis Protein | 2011 |